Completed PHASE2 INTERVENTIONAL NCT00004787

Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes

Sponsor: James Whitcomb Riley Hospital for Children

Conditions Dyskeratosis Congenita Fanconi's Anemia Shwachman Syndrome Thrombocytopenia

Interventions filgrastim

Updated 5 times since 2017 Last updated: Jun 23, 2005 Started: Dec 31, 1994

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00004787, this PHASE2 trial focuses on Dyskeratosis Congenita and Fanconi's Anemia and remains completed. Sponsored by James Whitcomb Riley Hospital for Children, it has been updated 5 times since 1994, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Dec 1994

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

James Whitcomb Riley Hospital for Children
National Center for Research Resources (NCRR)

Data source: Office of Rare Diseases (ORD)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.